Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics clinical studies Novabiotics pipeline Novabiotics our news Novabiotics contact
Date posted: 5 December 2023

NovaBiotics are pleased to announce that we will be participating in the 42nd European Cystic Fibrosis Conference (ECFS); 5-8 June 2019, Liverpool.

Our team will be presenting exciting new data on the antimicrobial mechanism of action, mucolytic mechanism of action and recent clinical data for our oral and inhaled CF drug candidates, Lynovex.…